Showing results (641-650 of 1,238) with videos related to
Sort By:
Pageof 124
Cancer Treatment and Research Communications|February 20, 2021
Impact of high-risk features for stage II adenocarcinoma of the appendixMehmet Akce, Katerina Zakka, McKenna Penley, et al.Cancer Treatment and Research Communications|February 22, 2021
COVID-19 and cancer: A comparative case seriesSeied Asadollah Mousavi, Tahereh Rostami, Azadeh Kiumarsi, et al.Cancer Treatment and Research Communications|October 22, 2018
Is quantitative sensory testing helpful in the management of oxaliplatin neuropathy? a two-year clinical studyJ B Delmotte, H Beaussier, N Auzeil, et al.Cancer Treatment and Research Communications|March 4, 2019
The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1)Omar Najim, Manon Huizing, Konstantinos Papadimitriou, et al.Cancer Treatment and Research Communications|December 17, 2021
Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung CancerJacqueline V Aredo, Heather A Wakelee, Joel W Neal, et al.Cancer Treatment and Research Communications|July 13, 2019
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421P N Lara, M Plets, C Tangen, et al.Cancer Treatment and Research Communications|July 13, 2019
Pregnancy associated acute leukemia: Single center experienceMohamed Mabed, Noha Eisa, Shaimaa El-Ashwah, et al.Cancer Treatment and Research Communications|August 30, 2022
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes projectJohn Bridgewater, Xiaolong Jiao, Mounika Parimi, et al.Cancer Treatment and Research Communications|September 26, 2022
Deep sequencing reveals the spectrum of BCR-ABL1 mutations upon front-line therapy resistance in chronic myeloid leukemia: An Eastern-Indian cohort studySamya Dey, Soumi Basu, Shahena Shah, et al.Cancer Treatment and Research Communications|September 26, 2022
Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trialsPatrick L Sweeney, Albert Jang, Shams K Halat, et al.Pageof 124